We are live on ! Find out more
SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

193 hedge funds and large institutions have $1.21B invested in Sage Therapeutics in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 83 increasing their positions, 44 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $8.57M

89% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 44

7.65% more ownership

Funds ownership: 90.53%98.17% (+7.6%)

14% less funds holding

Funds holding: 224193 (-31)

47% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 60

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

52% less capital invested

Capital invested by funds: $2.54B → $1.21B (-$1.33B)

Holders
193
Holders Change
-31
Holders Change %
-13.84%
% of All Funds
3.06%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
83
Reduced
44
Closed
60
Calls
$19.5M
Puts
$8.57M
Net Calls
+$11M
Net Calls Change
+$6M
Name Holding Trade Value Shares
Change
Change in
Stake
CSPIA
251
Cary Street Partners Investment Advisory
Virginia
-$3.29K -70 Closed
DI
252
Disciplined Investments
Oklahoma
-$329 -7 Closed
SFG
253
Steward Financial Group
Texas
+$404 +14 New